Colitis ulcerosa: nyitott vizsgálatok itt: Görögország
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozResearch participation
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
- Where
- Athens, Heraklion, Ioannina, Kifissia
- Age
- 18 év and over
- People
- 593 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2023-507853-13-00EU 2023-507853-13-00Regiszter frissítve: 2026-11-09
2. fázisCsak meghívásosTrial-stage medicine
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
- Where
- Athens, Chaïdári, Heraklion, Patras
- Age
- 18 év and over
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07652294EU 2025-524640-35-00Regiszter frissítve: 2026-11-09
3. fázisToborozTrial-stage medicine
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Athens, Heraklion, Thessaloniki
- Age
- 18 év to 70 év
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086EU 2024-520209-38-00Regiszter frissítve: 2026-11-04
2. fázisToborozTrial-stage medicine
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Where
- Athens, Heraklion, Thessaloniki
- Age
- 18 év to 80 év
- People
- 1431 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07415044Regiszter frissítve: 2026-11-04
3. fázisToborozTrial-stage medicine
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Athens, Heraklion, Ioannina, Piraeus
- Age
- 18 év and over
- People
- 644 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07577856EU 2026-525923-26-00Regiszter frissítve: 2026-11-03
1/2. fázisToborozTrial-stage medicine
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Where
- Athens, Heraklion, Thessaloniki
- Age
- 18 év to 75 év
- People
- 270 worldwide
- Run by
- Xencor, Inc.
See details and how to joinNCT06619990Regiszter frissítve: 2026-10-30
2. fázisToborozTrial-stage medicine
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Where
- Athens, Chaïdári, Heraklion, Patras
- Age
- 18 év to 75 év
- People
- 645 worldwide
- Run by
- Spyre Therapeutics, Inc.
See details and how to joinNCT07012395EU 2025-521242-26-00Regiszter frissítve: 2026-10-27
3. fázisToborozTrial-stage medicine
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Where
- Athens, Thessaloniki
- Age
- 2 év to 17 év
- People
- 120 worldwide
- Run by
- AbbVie
See details and how to joinNCT07071519EU 2024-514695-41-00Regiszter frissítve: 2026-10-27
3. fázisToborozResearch participation
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
- Where
- Athens, Chaïdári, Efkarpia, Thessaloniki
- Age
- Up to 17 év
- People
- 68 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to join2024-511458-32-00EU 2024-511458-32-00Regiszter frissítve: 2026-10-26
2. fázisToborozTrial-stage medicine
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Where
- Athens
- Age
- 18 év to 75 év
- People
- 100 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07463183EU 2025-523479-49-00Regiszter frissítve: 2026-10-23
2. fázisToborozResearch participation
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
- Where
- Athens, Heraklion, Thessaloniki
- Age
- 18 év and over
- People
- 104 worldwide
- Run by
- Eli Lilly & Co.
See details and how to join2025-524404-29-00EU 2025-524404-29-00Regiszter frissítve: 2026-10-21
1. fázisToborozTrial-stage medicine
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Crohn's Disease or Ulcerative Colitis
- Where
- Athens
- People
- 15 worldwide
- Run by
- The Foundation for Orthopaedics and Regenerative Medicine
See details and how to joinNCT05003947Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
- Where
- Athens, Efkarpia, Thessaloniki
- Age
- 8 év to 18 év
- People
- 80 worldwide
- Run by
- Alfasigma S.p.A.
See details and how to joinNCT06865417Regiszter frissítve: 2026-10-20
3. fázisToborozTrial-stage medicine
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Where
- Athens
- Age
- 16 év to 80 év
- People
- 751 worldwide
- Run by
- Sanofi
See details and how to joinNCT07185009Regiszter frissítve: 2026-10-16
2. fázisToborozTrial-stage medicine
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Where
- Athens, Heraklion, Patras
- Age
- 18 év to 75 év
- People
- 192 worldwide
- Run by
- Takeda
See details and how to joinNCT06764615EU 2024-518914-18-00Regiszter frissítve: 2026-05-22
3. fázisToborozTrial-stage medicine
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Where
- Athens, Thessaloniki
- Age
- 2 év to 17 év
- People
- 240 worldwide
- Run by
- Takeda
See details and how to joinNCT05442567EU 2023-509046-36-00Regiszter frissítve: 2026-05-07
Minden vizsgálat (Colitis ulcerosa) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.